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Purpose/Objective: Having established the role of voluntary 
deep-inspiration breath hold (VBH) in reducing incidental 
cardiac irradiation for women receiving left breast 
radiotherapy, a clinical audit was conducted to inform the 
routine implementation of this technique in 2013. In 2014, a 
subsequent audit was carried out to determine the current 
required time for this technique in comparison to our 
‘standard’ free-breathing (FB) technique and our previously 
assessed time. In addition, whether information about the 
technique had been provided to the patient by clinicians was 
also recorded.  
Materials and Methods: Patients referred for radiotherapy 
using VBH were included in this audit. Patients were divided 
into groups according to treatment technique: VBH 
tangentials, VBH tangentials and supraclavicular fossa (SCF), 
‘standard’ FB tangentials and ‘standard’ FB tangentials and 
SCF. Patients were questioned about their understanding of 
the technique and whether they felt it tolerable, i.e., able to 
maintain breath hold for 20 seconds. Training and scanning 
times were recorded at pre-treatment and delivery time of 
each fraction at treatment. Patients whose techniques take 
longer to deliver e.g. 4-field SCF and axilla patients or 
entirely-bolused fields were excluded as these did not offer a 
fair time comparison. Patients with co-morbidities (poor 
mobility or reduced arm movement) were included as they 
are representative of the range of patients currently treated 
in our department.  
Results: 24 patients were timed at CT and on treatment. Of 
360 fractions 163 had complete data. The time required for 
VBH tangentials from 2013 to 2014 was reduced by a mean 
time of 5-10 minutes at CT, and by 4 mins on treatment 
(table 1).  
9 out of 16 patients were provided with information about 
the VBH technique by the clinician prior to their CT planning 
scan. 
Table 1. A comparison of timings from 2013 & 2014. Mean 
data with ranges in brackets. 
 
 
Conclusions: This audit has demonstrated that as the VBH 
technique becomes routine, the efficiency of the process 
improves. The VBH + SCF technique currently takes longer 
than the ‘standard’ FB tangentials + SCF to scan and deliver, 
but this can also reasonably be expected to reduce, as has 
been observed for VBH tangentials.  
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Purpose/Objective: Aim of this hypothesis-generating 
prospective study was to define dose-volume parameters for 
Grade 3 (G3) mucositis in patients treated with 
radio(chemo)therapy for HNSCC. For this we defined a 
common ontology among experts for HNSCC delineators based 
on clear anatomical structures. 
Materials and Methods: 57 HNSCC patients (44 post-op, 13 
primary) were prospectively enrolled in a two-arm 
randomized study comparing two different tea-formulas as 
supportive measure during radio(chemo)therapy between 
April 2012 and June 2014. The protocol was approved by the 
institutional ethics committee. Acute toxicity was scored 
before, twice weekly during and after treatment according to 
the RTOG/EORTC system. No differences in mucositis were 
observed between the two arms and the pooled prospective 
scoring data were used post-hoc for analysis of dose-volume 
parameters. Three expert radiation oncologists defined an 
ontology for mucosa delineation based on anatomical 
structures' boundaries of CT scans (table 1, figure 1). All 
patients were delineated according to these principles. 
Dmax, Dmean, V20, V30, V40, V50 and V60 were evaluated 
and correlated with occurrence of mucositis G3. Statistical 
analysis was performed using t-tests, ROC-curves, negative 
and positive predictive values (SPSS Statistics version 21). 
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Results: 47 male and 10 female patients were enrolled, 
median age was 61 years. All patients underwent 
radio(chemo)therapy for HNSCC, two patients who did not 
receive the prescribed dose, were excluded from further 
analysis. Mucositis G3 was observed in 21 patients and 
occurred between 17 and 50 days (mean 33d, ±SD 9d) after 
start of treatment. The contoured mucosal volumes ranged 
from 48cc to105cc (mean 68cc, ±SD 12cc). Univariate analysis 
revealed a significant difference of Dmax (p<0.0001) and V30 
(p=0.035) between patients with and without mucositis G3. 
ROC-curves indicated optimal cut off values of 68Gy for Dmax 
and V30≤73%. The positive predictive values were 56% and 
50%. The negative predictive values were 87% and 81%, 
respectively.  
Conclusions: A delineation consensus of the oral cavity 
mucosa based on anatomical borders on planning CTs was 
developed and successfully applied. The large negative 
predictive values of Dmax and V30 suggest that 
pretherapeutic identification of patients with a low risk of 
mucositis Grade 3 within a given treatment regimen is 
feasible. This information may be utilized for risk-
stratification of patients. The hypothesis generated in our 
study will now be validated in a prospective observational.  
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Purpose/Objective: Preoperative Radiotherapy or Chemo-
Radiotherapy for locally advanced rectal cancer (LARC) can 
cause acute and long-term small bowel (SB) side effects. 
Currently at the St Luke’s Radiation Oncology Network, 
preoperative LARC patients are treated using a 3D conformal 
radiotherapy (3DCRT). There is a dose volume relationship 
between small bowel irradiation and the development of 
acute grade diarrhoea1. Intensity Modulated Radiotherapy 
(IMRT) can improve SB sparing, which may thus reduce 
toxicity2. A planning study was undertaken to assess the 
reduction of SB dose, while maintaining PTV coverage using 
the options available within the VMAT optimizer in Eclipse, 
namely Avoidance Structures and Avoidance Sectors.  
Materials and Methods: Methods: A planning study was 
carried out on a total of 20 LARC patients with the aim of a 
significantly reducing the dose received by the SB. Patients 
were planned supine, with a full bladder and given IV 
contrast. No oral contrast was administered. Standard 
preoperative rectal volumes were drawn, based upon RTOG 
guideline, with the addition of bowel loops (small bowel and 
large bowel) for the purpose of assessment. For each of the 
20 patients, 5 plans were created:  
